Additionally, the mTOR inhibitor “sirolimus” [17], as well as the calcineurin inhibitor “tacrolimus” [18], were recognized as potent modulators of the lupus monocyte gene signature. This evidence concerns the gene MTOR and systemic lupus erythematosus.